个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
周一盘中交易时段,12只医疗保健类股走势
Gainers
- Nymox Pharmaceutical (NASDAQ:NYMX) shares increased by 32.7% to $0.38 during Monday's regular session. As of 12:30 EST, Nymox Pharmaceutical's stock is trading at a volume of 3.2 million, which is 4414.3% of its average full-day volume over the last 100 days. The company's market cap stands at $34.3 million.
- SCWorx (NASDAQ:WORX) shares moved upwards by 28.95% to $0.72. As of 12:30 EST, SCWorx's stock is trading at a volume of 202.1K, which is 441.6% of its average full-day volume over the last 100 days. The company's market cap stands at $9.4 million.
- Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 24.87% to $3.01. The current volume of 22.2 million shares is 899.0% of Shuttle Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $40.7 million.
- Vivani Medical (NASDAQ:VANI) stock rose 24.53% to $1.72. As of 12:30 EST, this security is trading at a volume of 242.3K shares, making up 419.5% of its average full-day volume over the last 100 days. The company's market cap stands at $87.1 million.
- Yumanity Therapeutics (NASDAQ:YMTX) stock rose 20.93% to $2.08. Trading volume for this security as of 12:30 EST is 1.3 million, which is 4022.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $22.5 million.
- Iovance Biotherapeutics (NASDAQ:IOVA) shares moved upwards by 20.39% to $8.23. Trading volume for this security as of 12:30 EST is 11.8 million, which is 406.3% of its average full-day volume over the last 100 days. The company's market cap stands at $1.2 billion.
Losers
- Dermata Therapeutics (NASDAQ:DRMA) shares declined by 59.8% to $0.26 during Monday's regular session. The current volume of 4.9 million shares is 2582.3% of Dermata Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $3.1 million.
- Meihua Intl Medical Techs (NASDAQ:MHUA) shares decreased by 26.29% to $9.79. Meihua Intl Medical Techs's stock is trading at a volume of 51.7K shares as of 12:30 EST. This is 204.0% of its average full-day volume over the last 100 days. The company's market cap stands at $234.3 million.
- Ampio Pharmaceuticals (AMEX:AMPE) shares declined by 17.05% to $0.29. Trading volume for this security as of 12:30 EST is 119.2K, which is 28.4% of its average full-day volume over the last 100 days. The company's market cap stands at $4.3 million.
- Gelesis Holdings (NYSE:GLS) shares decreased by 16.65% to $0.4. The market value of their outstanding shares is at $29.2 million.
- Enochian BioSciences (NASDAQ:ENOB) shares declined by 15.13% to $1.01. Trading volume for this security as of 12:30 EST is 87.9K, which is 175.5% of its average full-day volume over the last 100 days. The company's market cap stands at $53.4 million.
- Clovis Oncology (NASDAQ:CLVS) stock declined by 12.72% to $0.3. Trading volume for Clovis Oncology's stock is 2.2 million as of 12:30 EST. This is 55.9% of its average full-day volume over the last 100 days. The company's market cap stands at $43.5 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Gainers
获胜者
- Nymox Pharmaceutical (NASDAQ:NYMX) shares increased by 32.7% to $0.38 during Monday's regular session. As of 12:30 EST, Nymox Pharmaceutical's stock is trading at a volume of 3.2 million, which is 4414.3% of its average full-day volume over the last 100 days. The company's market cap stands at $34.3 million.
- SCWorx (NASDAQ:WORX) shares moved upwards by 28.95% to $0.72. As of 12:30 EST, SCWorx's stock is trading at a volume of 202.1K, which is 441.6% of its average full-day volume over the last 100 days. The company's market cap stands at $9.4 million.
- Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 24.87% to $3.01. The current volume of 22.2 million shares is 899.0% of Shuttle Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $40.7 million.
- Vivani Medical (NASDAQ:VANI) stock rose 24.53% to $1.72. As of 12:30 EST, this security is trading at a volume of 242.3K shares, making up 419.5% of its average full-day volume over the last 100 days. The company's market cap stands at $87.1 million.
- Yumanity Therapeutics (NASDAQ:YMTX) stock rose 20.93% to $2.08. Trading volume for this security as of 12:30 EST is 1.3 million, which is 4022.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $22.5 million.
- Iovance Biotherapeutics (NASDAQ:IOVA) shares moved upwards by 20.39% to $8.23. Trading volume for this security as of 12:30 EST is 11.8 million, which is 406.3% of its average full-day volume over the last 100 days. The company's market cap stands at $1.2 billion.
- Nymox 制药 纳斯达克股票代码:NYMX)股价在周一的例会上上涨了32.7%,至0.38美元。截至美国东部标准时间 12:30,Nymox Pharmaceutical 的股票交易量为320万股,占其过去100天平均全日交易量的4414.3%。该公司的市值为3430万美元。
- scWorx 纳斯达克股票代码:WORX)的股价上涨了28.95%,至0.72美元。截至美国东部标准时间 12:30,scWorx的股票交易量为202.1K,占其过去100天平均全日交易量的441.6%。该公司的市值为940万美元。
- 航天制药 纳斯达克股票代码:SHPH)股价上涨24.87%,至3.01美元。目前的2220万股成交量是Shuttle Pharmicals过去100天(上次更新时间为美国东部标准时间 12:30)平均全日成交量的899.0%。该公司的市值为4,070万美元。
- 维瓦尼医疗 纳斯达克股票代码:VANI)股价上涨24.53%,至1.72美元。截至美国东部标准时间 12:30,该证券的交易量为242.3万股,占其过去100天平均全日交易量的419.5%。该公司的市值为8,710万美元。
- 人类疗法 纳斯达克股票代码:YMTX)股价上涨20.93%,至2.08美元。截至美国东部标准时间 12:30,该证券的交易量为130万,占其过去100天平均全日交易量的4022.8%。他们已发行股票的市值为2,250万美元。
- Iovance 生物疗法 纳斯达克股票代码:IOVA)的股价上涨了20.39%,至8.23美元。截至美国东部标准时间 12:30,该证券的交易量为1180万,占其过去100天平均全日交易量的406.3%。该公司的市值为12亿美元。
Losers
失败者
- Dermata Therapeutics (NASDAQ:DRMA) shares declined by 59.8% to $0.26 during Monday's regular session. The current volume of 4.9 million shares is 2582.3% of Dermata Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $3.1 million.
- Meihua Intl Medical Techs (NASDAQ:MHUA) shares decreased by 26.29% to $9.79. Meihua Intl Medical Techs's stock is trading at a volume of 51.7K shares as of 12:30 EST. This is 204.0% of its average full-day volume over the last 100 days. The company's market cap stands at $234.3 million.
- Ampio Pharmaceuticals (AMEX:AMPE) shares declined by 17.05% to $0.29. Trading volume for this security as of 12:30 EST is 119.2K, which is 28.4% of its average full-day volume over the last 100 days. The company's market cap stands at $4.3 million.
- Gelesis Holdings (NYSE:GLS) shares decreased by 16.65% to $0.4. The market value of their outstanding shares is at $29.2 million.
- Enochian BioSciences (NASDAQ:ENOB) shares declined by 15.13% to $1.01. Trading volume for this security as of 12:30 EST is 87.9K, which is 175.5% of its average full-day volume over the last 100 days. The company's market cap stands at $53.4 million.
- Clovis Oncology (NASDAQ:CLVS) stock declined by 12.72% to $0.3. Trading volume for Clovis Oncology's stock is 2.2 million as of 12:30 EST. This is 55.9% of its average full-day volume over the last 100 days. The company's market cap stands at $43.5 million. See Also:
- Dermata Therapeu 纳斯达克股票代码:DRMA)股价在周一的例行交易中下跌了59.8%,至0.26美元。目前的490万股成交量是Dermata Therapeutics过去100天(上次更新时间为美国东部标准时间 12:30)平均全日成交量的2582.3%。他们已发行股票的市值为310万美元。
- 梅华国际医疗科技 纳斯达克股票代码:MHUA)股价下跌26.29%,至9.79美元。截至美国东部标准时间 12:30,梅华国际医疗科技的股票交易量为51.7万股。这是其过去 100 天平均全日交易量的204.0%。该公司的市值为2.343亿美元。
- 安皮奥制药 (AMEX: AMPE)股价下跌17.05%,至0.29美元。截至美国东部标准时间 12:30,该证券的交易量为11.92万,占其过去100天平均全日交易量的28.4%。该公司的市值为430万美元。
- 吉莱西斯控股公司 纽约证券交易所代码:GLS)股价下跌16.65%,至0.4美元。他们已发行股票的市值为2920万美元。
- Enochian 生物科学 纳斯达克股票代码:ENOB)股价下跌15.13%,至1.01美元。截至美国东部标准时间 12:30,该证券的交易量为87.9K,占其过去100天平均全日交易量的175.5%。该公司的市值为5,340万美元。
- 克洛维斯肿瘤学 纳斯达克股票代码:CLVS)股价下跌12.72%,至0.3美元。截至美国东部标准时间 12:30,Clovis Oncology股票的交易量为220万股。这是其过去 100 天平均全日交易量的55.9%。该公司的市值为4,350万美元。 另请参阅:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!